ISCO
International Stem Cell Corporation
Other OTC
People also watch:BTXSCONNNVCCURNBS
2.000.10 (5.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close1.90
Open1.99
Bid0.00 x
Ask0.00 x
52wk Range1.90 - 2.00
Day's Range1.99 - 2.00
Volume628
Avg Vol (3m)3,300
As of 11:32 AM EDT. Other OTC Delayed Price. Market open.
  • International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016
    Capital Cube2 months ago

    International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016

    Click here to see latest analysisInternational Stem Cell Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of International Stem Cell Corp. – Keryx Biopharmaceuticals, Inc., Opexa Therapeutics, Inc., Celgene Corporation, Anthera Pharmaceuticals, Inc., Chimerix, Inc. and Vericel Corporation (KERX-US, OPXA-US, CELG-US, ANTH-US, CMRX-US and […] (Read more...) The post International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016 appeared first on CapitalCube.

  • International Stem Cell Corp. Earnings Q3, 2015
    Capital Cube8 months ago

    International Stem Cell Corp. Earnings Q3, 2015

    Click here to see latest analysisInternational Stem Cell Corp. reports financial results for the quarter ended September 30, 2015.We analyze the earnings along side the following peers of International Stem Cell Corp. – Keryx Biopharmaceuticals, Inc., Opexa Therapeutics, Inc., Celgene Corporation, Anthera Pharmaceuticals, Inc., Chimerix, Inc. and Vericel Corporation (KERX-US, OPXA-US, CELG-US, ANTH-US, CMRX-US and […] (Read more...) The post International Stem Cell Corp. Earnings Q3, 2015 appeared first on CapitalCube.